Candidate Dukakis Now Favors The Space Station

WASHINGTON—Presidential candidates are often criticized for being vague. But Michael Dukakis has learned the hard way that it also doesn't pay to be specific. He's had to change his stand on the space station. Constantly pressed to cite areas where the Democratic standard bearer would trim the federal deficit, the Dukakis campaign used to mention the $30 billion space station as one potential target-this despite the fact that the candidate endorsed the concept of a space station. In the pa

Written byG. Christopher Anderson
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Constantly pressed to cite areas where the Democratic standard bearer would trim the federal deficit, the Dukakis campaign used to mention the $30 billion space station as one potential target-this despite the fact that the candidate endorsed the concept of a space station. In the past, Dukakis reconciled these positions by saying that there might be less costly alternatives, including an unmanned facility, that could accomplish the same scientific goals. But since the Democratic primary, his universe has changed—at least with regard to the space station.

Last month, a dozen House and Senate Democrats read Dukakis aides the riot act on the candidate's tepid support for the orbiting station. At a closed-door meeting August 9, they told his issues director, Christopher Edley, that it would be hard for Dukakis to carry such crucial states as Ohio, Texas, and Florida without a stronger endorsement of the project. And they reminded Edley ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies